Pfizer makes ‘business decision’ to end phase 2 trial of autoimmune drug as program’s future uncertain - Fierce Biotech

Pfizer Ends Phase 2 Trial of Autoimmune Drug, Future Uncertain

Pfizer has made the business decision to end the phase 2 trial of its autoimmune drug, leaving the program's future in uncertainty. This comes as a surprise to the Fierce Biotech community.